Twinbeech Capital LP Keros Therapeutics, Inc. Transaction History

Twinbeech Capital LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$10.15 - $16.1 $323,541 - $513,203	-31,876 Reduced 24.6%	97,677 $995,000
Q4 2024 Feb 14, 2025	BUY	$15.64 - $70.0 $1.79 Million - $7.99 Million	114,175 Added 742.46%	129,553 $2.05 Million
Q3 2024 Nov 14, 2024	SELL	$41.68 - $58.07 $1.4 Million - $1.95 Million	-33,610 Reduced 68.61%	15,378 $893,000
Q2 2024 Aug 14, 2024	BUY	$44.58 - $66.89 $2.18 Million - $3.28 Million	48,988 New	48,988 $2.24 Million

169

35.4M

574K

325K

Ticker KROS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,757,000
Market Cap $445M
Description
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

Stay updated on Twinbeech Capital LP with notifications on news.